Aug . 06, 2026 13:36 Back to list
As the demand for rapid and accurate molecular diagnostics continues to grow, testing is no longer expected to remain exclusively within central laboratories.
Today, community hospitals, regional laboratories, outpatient clinics, emergency departments, and other decentralized healthcare settings are increasingly adopting molecular diagnostics to support faster clinical decision-making and expand access to high-quality testing.
This shift is reshaping the way molecular testing is delivered—from centralized laboratory services toward more accessible testing closer to patients.
Designed for this evolving landscape, the NATBox® Molecular POCT System extends laboratory-quality molecular testing beyond the central laboratory through an integrated sample-to-result workflow. It enables more healthcare facilities to perform reliable real-time PCR testing with greater flexibility and operational simplicity.
Because the future of molecular diagnostics is not about replacing central laboratories—it's about making molecular testing accessible wherever it can create greater clinical value.

NATBox®
Bringing Molecular Diagnostics Beyond the Central Laboratory.
Click to view the LinkedIn post
(https://www.linkedin.com/feed/update/urn:li:activity:7491002371117047809)
Related PRODUCTS
Meet COWIN GENE at WHX Bangkok 2026!
NewsJun.09,2026Supporting Ebolavirus Surveillance with Real-time PCR Detection
NewsMay.27,20267 Days To Go Until Whx Lagos 2026!
NewsMay.26,2026When the Clinical Picture Is Not Specific, Should Testing Be?
NewsSep.11,2026TB Diagnosis Is Moving Closer to the Point of Care
NewsSep.10,2026Why 28 HPV Types?
NewsSep.02,2026